Adam Levin - Jun 23, 2022 Form 4 Insider Report for Ensysce Biosciences, Inc. (ENSC)

Role
Director
Signature
/s/ Adam Levin
Stock symbol
ENSC
Transactions as of
Jun 23, 2022
Transactions value $
$0
Form type
4
Date filed
6/27/2022, 05:35 PM
Previous filing
Feb 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENSC Stock Option Award +15K +75% 35K Jun 23, 2022 Common Stock 15K $0.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 23, 2022, Mr. Levin was granted an option (the "Stock Option") to purchase 15,000 shares of common stock of Ensysce Biosciences, Inc. (the "Company"), par value $0.0001 per share, with a per share exercise price of $0.425, under the Amended and Restated 2021 Omnibus Incentive Plan of the Company. The Stock Option vests 1/12th per month over one year.